Physician profile
Michael T Margolis
NPI 1467475046
$840.59
in general payments reported to CMS, 2019-2025
17 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $92.43 · 2021: $195 · 2022: $119 · 2023: $67.89 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $223.78 | 2019-2022 | |
| Coloplast Corp | $192.54 | 2023-2025 | Saffron |
| Biohaven Pharmaceutical Holding Company LTD. | $62.58 | 2022 | |
| Roche Diagnostics Corporation | $56.30 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.24 | 2020-2021 | |
| Therapeuticsmd, INC. | $37.18 | 2019-2022 | |
| Acell, INC. | $31.98 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $29.74 | 2021 | |
| Abbott Laboratories | $23.88 | 2023 | Proclaim |
| Axonics, INC. | $23.07 | 2023 | Axonics |
| Myovant Sciences INC. | $18.67 | 2021 | |
| Astellas Pharma US INC | $18.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.38 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.34 | 2021 | |
| Medtronic, INC. | $18.24 | 2025 | Rapidvac |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $15.84 | 2021 | |
| Exeltis, USA INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Margolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.